Severe Dyslipidaemia After the Addition of Raltegravir to a Lopinavir/Ritonavir-Containing Regimen
Antiviral Therapy - United Kingdom
doi 10.3851/imp2182
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
International Medical Press